COVID-19 -- United Kingdom
As the international effort to vaccinate the population against COVID-19 gathers pace, the demand for vaccine doses that can be used in all countries and climates is enormous. Researchers from Cleveland Clinic [Ohio, USA] and Chungbuk National University [Cheongju, South Korea] have described a new vaccine candidate that triggers an immune response using antigens attached to nanoparticles, potentially bypassing the need for cold storage during delivery. They report their findings in mBio [see
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?8262023&promed&0
No comments:
Post a Comment